EG-70 (phase 1)
EG-70-101
Phase 2 small_molecule active
Quick answer
EG-70 (phase 1) for Superficial Bladder Cancer is a Phase 2 program (small_molecule) at enGene Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- enGene Therapeutics
- Indication
- Superficial Bladder Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active